The FDA has granted 510(k) clearance to a Bay Area medical technology firm for its proprietary delirium monitoring solution, ...

The investigational aldosterone synthase inhibitor lorundrostat demonstrated efficacy in reducing systolic blood pressure and albuminuria for patients with uncontrolled hypertension and chronic kidney ...

JAK inhibitor treatment is not associated with stunted growth in children with common inflammatory diseases, according to a ...

In this video, Halle C. F. Moore, MD, discusses the EMBER-3 study update evaluating imlunestrant for women with hormone receptor-positive, HER2-negative breast cancer, presented at San Antonio Breast ...

A quality improvement initiative improved rates of lipid screening among children and adolescents and may improve downstream ...

In this video, Jennifer A. Ligibel, MD, discusses results from the ASCENT-07 trial, in which sacituzumab govitecan did not meet its primary endpoint of PFS for patients with endocrine ...

A selective androgen receptor modulator combined with a GLP-1 may induce weight loss for older adults with obesity while ...

In-hospital mortality by day 28 did not significantly differ based on use of ketamine or etomidate to induce anesthesia in ...

A national prospective study has confirmed a long-suspected link between Agent Orange and a rare but serious form of blood ...

This is part one of a three-part Healio Exclusive series on work-life balance among women physicians. Part two and part three ...

In this video, Matthew S. Davids, MD, said data from the BRUIN-313 trial supports front-line approval of pirtobrutinib in patients with previously untreated chronic lymphocytic leukemia or small ...

Patients with eosinophilic granulomatosis with polyangiitis who received 2 years of treatment with the interleukin-5 ...